Challenges Based on Antiplasmodial and Antiviral Activities of 7-Chloro-4-aminoquinoline Derivatives. 2023

Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
Center for Bioinformatics and Molecular Medicine, Nagasaki University, 1-14 Bunkyo, 852-8521, Nagasaki, Japan.

We report the structural functionalization of the terminal amino group of N1 -(7-chloroquinolin-4-yl) butane-1,4-diamine, leading to a series of 7-chloro-4-aminoquinoline derivatives, and their evaluation as potent anti-malarial and anti-viral agents. Some compounds exhibited promising anti-malarial effects against the Plasmodium falciparum 3D7 (chloroquine-sensitive) and Dd2 (chloroquine-resistant) strains. In addition, these compounds were assayed in vitro against influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Compound 5 h, bearing an N-mesityl thiourea group, displayed pronounced anti-infectious effects against malaria, IAV, and SARS-CoV-2. These results provide new insights into drug discovery for the prevention or treatment of malaria and virus co-infection.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
October 2018, Bioorganic chemistry,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
October 2012, Bioorganic & medicinal chemistry,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
May 1969, Journal of medicinal chemistry,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
September 2012, Bioorganic & medicinal chemistry letters,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
October 2012, Bioorganic & medicinal chemistry,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
December 2016, Experimental parasitology,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
January 1946, Journal of the American Chemical Society,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
November 1985, Journal of chromatography,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
July 2014, Bioorganic & medicinal chemistry,
Satoshi Mizuta, and Farhana Mosaddeque, and Mya Myat Ngwe Tun, and Awet Alem Teklemichael, and Mayumi Taniguchi, and Masashi Hosokawa, and Tomoko Yamaguchi, and Juliann Makau, and Nguyen Tien Huy, and Shusaku Mizukami, and Noriyuki Nishida, and Kouichi Morita, and Kenji Hirayama
August 1946, Journal of the American Chemical Society,
Copied contents to your clipboard!